From preclinical research to regulatory approval and clinical adoption, diagnostic testing underpins every stage of ADC ...

The theory behind antibody drug conjugates (ADCs) is simple yet elegant: by combining the specificity of a monoclonal antibody with the cytotoxicity of a potent small molecule drug, ADCs can ...

A new study shows how an anticancer drug triggers an “outside in” signal that gets it sucked into a cancer cell.

New York, United States, Jan. 22, 2025 (GLOBE NEWSWIRE) -- ADCs, or antibody-drug conjugates, are chemotherapeutic agents explicitly designed to treat cancer cells. Antibody-drug conjugates ...